page_banner

news

CCTV network report: Epiprobe Biotech 100,000 cases of cervical cancer screening research cohort study officially launched!

Eliminate cervical cancer, Yi spectrum in action. CCTV network on March 6 published a news video of the launch of a large-scale public welfare project to prevent cervical cancer in Shandong Province "Eliminating cervical cancer and building a healthy Chinese Dream".

In order to actively respond to the "Global Strategy for Accelerating the Elimination of Cervical Cancer" proposed by the World Health Organization, thoroughly implement the "Healthy China 2030" plan Outline and the "Chinese Women's Development Outline (2021-2030)", continue to promote the "Caring for Women's health" Qilu campaign, accelerate the process of eliminating cervical cancer, protect and improve the health of women, On March 5, the launch ceremony of Shandong Provincial cervical cancer Prevention large-scale public welfare project, co-sponsored by Shandong Provincial Women's Federation and Heze Municipal People's Government, sponsored by Shandong Provincial Maternal and Child Health Hospital and Shanghai Yipu Biotechnology Co., LTD., supported by Shanghai Medical College of Fudan University, Tumor Markers Professional Committee of Chinese Anti-Cancer Association and International Peace Maternal and Child Health Hospital affiliated to Shanghai Jiao Tong University, was held in Jinan. The leaders and guests attending the event are: Sun Fenghua, Secretary of the Party Group and Chairman of Shandong Women's Federation; Member and Deputy director of the Party Group of the Provincial Health Commission, Secretary and Director of the Party Group of the Provincial Disease Control Bureau; Nie Yuanke, Deputy Secretary of Heze Municipal Party Committee; Kong Beihua, Chairman of Gynecological Oncology Branch, Chinese Medical Association; Wang Yudong, President of the International Peace Maternal and Child Health Care Hospital Affiliated to Shanghai Jiao Tong University; Xing Jinliang, Chairman of the Tumor Markers Committee of the Chinese Anti-Cancer Association; Yu Wenqiang, Professor of Fudan University; Zheng Shicun, Party secretary of Shandong Provincial Maternal and Child Health Care Hospital. Wang Hongxia, member of the Party group and vice chairman of the Provincial Women's Federation, presided over the ceremony.

Sun Fenghua, Secretary of the Party Group and chairman of the Provincial Women's Federation, pointed out in his speech at the event that promoting the all-round development of women and improving the level of women's health is an important aspect of promoting the construction of healthy China and improving people's well-being, and it is the common responsibility of the whole society. It is hoped that women's federations at all levels in the province can fully understand the significance of caring for women's health, improve their political position, give full play to their functional advantages, take the initiative to act, promote the work of caring for women's health with high standards and high quality, effectively implement the public welfare project of preventing cervical cancer, do practical and good things that benefit women's health and well-being, and promote the cause of women's health in the province to a new level. It is hoped that the majority of women and sisters will enhance their awareness of self-health care and cancer prevention, cancer detection and cancer rejection, be the first responsible person for their own health, conduct regular health check-ups, drive family members to establish a health concept, practice a healthy lifestyle, drive family health with women's health, and help healthy Shandong construction. It is hoped that relevant departments and all sectors of society will continue to care about and support the cause of women's health, give full play to professional advantages, talent advantages and resource advantages, join hands and work together, gather a strong force of caring for women's health, and contribute to further improving the level of women's health protection in our province.

图片4

Nie Yuanke, deputy secretary of Heze Municipal Party Committee, said when attending the event and speaking that the large-scale public welfare project to prevent cervical cancer is a practical measure to promote the "action plan to accelerate the elimination of cervical cancer", and it is also a popular project to care for women's health. Heze will organize and implement this project well, make every effort to do a good job in project docking, service coordination, publicity and promotion, and ensure the high quality and efficient implementation of the project to benefit more women and families.

图片5
图片6

Wang Yudong, president of the International Peace Maternal and Child Health Care Hospital affiliated to Shanghai Jiao Tong University, and Yu Wenqiang, a researcher at the Institute of Biomedical Research of Fudan University and chief scientist of Shanghai Yipu Biotechnology Co., LTD., said that as the executive expert of the large-scale public welfare project to prevent cervical cancer in Shandong Province, they will lead a professional medical team through advanced screening technology and scientific management means. Cytology examination combined with gene methylation detection has been used to provide free, comprehensive and accurate cervical cancer screening services to 100,000 women of appropriate age in Shandong Province, promote the prevention of cancer before it is diagnosed and the early treatment of cancer, and do our best to improve women's health and well-being and improve women's health.

图片7

At the event, the participating leaders jointly launched a large-scale public welfare project to prevent cervical cancer in Shandong Province.

图片8

At the event, the International Peace Maternal and Child Health Hospital affiliated to Shanghai Jiao Tong University signed a cooperation agreement with Heze Maternal and Child Health Hospital. The two sides will establish a screening and management center of the CIS for Cervical cancer Prevention and Control, explore new models for cervical cancer screening, and establish long-term and stable cooperative relations in medical services, medical management, refresher training, and emergency and critical care referral, promote the sharing of quality medical resources, and improve regional maternal and child health care capabilities and medical service levels.

图片9
图片10

After the launch ceremony, a seminar on total cancer markers and new strategies for gynecological tumor diagnosis and treatment was held on site. Special guests Professor Xing Jinliang, Chairman of the Special Committee on Tumor Markers of the Chinese Anti-Cancer Association, Professor Wang Yudong, President of the International Peace Maternal and Child Health Care Hospital Affiliated to Shanghai Jiao Tong University, and Professor Kong Beihua, Chairman of the Gynecological Oncology Branch of the Chinese Medical Association, Qilu Hospital of Shandong University, made opening statements respectively.

图片11
图片12
图片13

In the keynote report session, the participating experts conducted academic exchanges around the theme of "Total cancer markers and new strategies for gynecological tumor diagnosis and treatment" : Professor Wang Yudong presided over, and Professor Kong Beihua delivered a report on "Prevention and Control Strategies for Cervical Cancer"; Song Kun, Professor of Qilu Hospital, Shandong University, and Wang Yudong, Professor of DNA methylation in early screening and early diagnosis of Cervical cancer. Professor Wang Jian, Vice President of the International Peace Maternal and Child Health Hospital Affiliated to Shanghai Jiao Tong University, presided over by Professor Li Yinshan, Secretary of the People's Hospital of Ningxia Hui Autonomous Region, and Dr. Zhang Qiaorui made a report on the application of total cancer marker PCDHGB7 in large-scale multi-center clinical cohort Screening of Cervical cancer in Ningxia. Presided over by Professor Zheng Shicun of Shandong Provincial Maternal and Child Health Hospital, Professor Yu Wenqiang of Fudan University introduced the design ideas, implementation process and expected results of large-scale public welfare project of prevention of cervical cancer in Shandong Province, analyzed the clinical diagnosis and treatment status and challenges faced by cervical diseases, and shared the experience and exploration of total cancer markers in the ultra-early diagnosis of cervical cancer.

图片14
图片15

In the round table dialogue session, as Professor Wen Qiang served as the host of the round table, Zheng Shicun, Secretary of Shandong Provincial Maternal and Child Health Hospital, Professor Wang Jian, Vice president of Shanghai Jiao Tong University Affiliated International Peace Maternal and Child Health Hospital, Professor Song Kun, Shandong University Qilu Hospital, and Professor Li Yinshan, Secretary of Ningxia Hui Autonomous Region People's Hospital, were the guests of the round table, and discussed the progress of the topic of "Marking the accurate escort of cancer". It broadens a new idea for the diagnosis and treatment of cervical cancer.

图片16

The symposium on Total Cancer Markers and new strategies for the diagnosis and treatment of gynecological tumors discussed new strategies and new methods for the prevention and treatment of cervical cancer and systematic solutions to improve the survival rate and quality of life of patients with cervical cancer, provided ideas for further improving the ability and level of women's health care, and built a platform for exchanges and cooperation for experts inside and outside the province, promoting the progress and development of the gynecological medical field.

The project of "Eliminating cervical cancer and building a healthy Chinese Dream" was officially launched, which means that the public welfare research cohort study of 100,000 cases of cervical cancer gene methylation screening by Epiprobe Biotech was officially launched. The aim of the project is to give back to the society, to benefit the people's livelihood with the scientific research results of the "whole cancer marker" PCDHGB7 methylation detection, and to further verify the excellent performance of the TAGMe DNA methylation screening technology for cervical and endometrial cancer. Epiprobe Biotech general manager Hua Lin said: for grassroots women 100,000 cases of cervical cancer gene methylation screening public welfare research cohort study was officially launched, Epiprobe Biotech mission such as pan, heavy responsibility, when firmly perform corporate social responsibility, do a good job in this screening work. With "early detection, early diagnosis and early treatment" as the core, we will solidly carry out 100,000 cases of cervical cancer cohort research, and contribute wisdom to help build a Shandong model of early screening and standardized diagnosis and treatment of cervical cancer.


Post time: Mar-13-2024